Ligand · QEI
QEI · 2-amino-5-({[(1S,4S,5R)-4,5-dihydroxycyclopent-2-en-1-yl]amino}methyl)-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one
QEI, 2-amino-5-({[(1S,4S,5R)-4,5-dihydroxycyclopent-2-en-1-yl]amino}methyl)-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one (C12 H15 N5 O3, 277.3 g/mol), in the MolNFT structures on GenesisL1: bound in 3 records (2 PDB entries). Every binding…
- Component
- QEI
- Formula
- C12 H15 N5 O3
- Class
- ligand
- Structures
- 3
- PDB entries
- 2
Binding sites
QEI in 3 structures; the first of them:
- 6H45 · crystal structure of the human TGT catalytic subunit QTRT1 in complex with queuine · QEI A501 · binds PHE109, ASP159, VAL161, VAL162, SER163, SER164, ILE200, GLN202 and 6 more
- 6H45 · Crystal structure of the human tgt catalytic subunit QTRT1 in complex with queuine · QEI A501 · binds PHE109, ASP159, VAL161, VAL162, SER163, SER164, ILE200, GLN202 and 6 more
- 7OVO · Heterodimeric murine tRNA-guanine transglycosylase in complex with queuine · QEI C501 · binds PHE109, GLN110, ASP159, VAL161, VAL162, SER163, SER164, ILE200 and 7 more
Residues it binds most
GLY 5, SER 5, VAL 5, ASP 5, ILE 5, LEU 5, MET 5, PHE 5, GLN 3 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.